|
1
|
Parolini O, Alviano F, Bagnara GP, Bilic
G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M,
Mao N, et al: Concise review: Isolation and characterization of
cells from human term placenta: Outcome of the first international
workshop on placenta derived stem cells. Stem cells. 26:300–311.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bollini S, Pozzobon M, Nobles M, Riegler
J, Dong X, Piccoli M, Chiavegato A, Price AN, Ghionzoli M, Cheung
KK, et al: In vitro and in vivo cardiomyogenic differentiation of
amniotic fluid stem cells. Stem Cell Rev. 7:364–380. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim SW, Zhang HZ, Kim CE, Kim JM and Kim
MH: Amniotic mesenchymal stem cells with robust chemotactic
properties are effective in the treatment of a myocardial
infarction model. Int J Cardiol. 168:1062–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katritsis DG, Sotiropoulou PA, Karvouni E,
Karabinos I, Korovesis S, Perez SA, Voridis EM and Papamichail M:
Transcoronary transplantation of autologous mesenchymal stem cells
and endothelial progenitors into infarcted human myocardium.
Catheter Cardiovasc Interv. 65:321–329. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeevanantham V, Butler M, Saad A,
Abdel-Latif A, Zuba-Surma EK and Dawn B: Adult bone marrow cell
therapy improves survival and induces long-term improvement in
cardiac parameters: A systematic review and meta-analysis.
Circulation. 126:551–568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hristov M, Heussen N, Schober A and Weber
C: Intracoronary infusion of autologous bone marrow cells and left
ventricular function after acute myocardial infarction: A
meta-analysis. J Cell Mol Med. 10:727–733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toma C, Pittenger MF, Cahill KS, Byrne BJ
and Kessler PD: Human mesenchymal stem cells differentiate to a
cardiomyocyte phenotype in the adult murine heart. Circulation.
105:93–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hua P, Liu JY, Tao J and Yang SR:
Application and progress of combined mesenchymal stem cell
transplantation in the treatment of ischemic cardiomyopathy. Biomed
Res Int. 2015:5685022015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Geng YJ: Molecular mechanisms for
cardiovascular stem cell apoptosis and growth in the hearts with
atherosclerotic coronary disease and ischemic heart failure. Ann N
Y Acad Sci. 1010:687–697. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hamedi-Asl P, Halabian R, Bahmani P,
Mohammadipour M, Mohammadzadeh M, Roushandeh AM,
Jahanian-Najafabadi A, Kuwahara Y and Roudkenar MH:
Adenovirus-mediated expression of the HO-1 protein within MSCs
decreased cytotoxicity and inhibited apoptosis induced by oxidative
stresses. Cell Stress Chaperones. 17:181–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang YL, Tang Y, Zhang YC, Qian K, Shen L
and Phillips MI: Improved graft mesenchymal stem cell survival in
ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J
Am Coll Cardiol. 46:1339–1350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He J, Wang C, Sun Y, Lu B, Cui J, Dong N,
Zhang M, Liu Y and Yu B: Exendin-4 protects bone marrow-derived
mesenchymal stem cells against oxygen/glucose and serum
deprivation-induced apoptosis through the activation of the
cAMP/PKA signaling pathway and the attenuation of ER stress. Int J
Mol Med. 37:889–900. 2016.PubMed/NCBI
|
|
13
|
Jin J, Jeong SI, Shin YM, Lim KS, Shin Hs,
Lee YM, Koh HC and Kim KS: Transplantation of mesenchymal stem
cells within a poly (lactide-co-epsilon-caprolactone) scaffold
improves cardiac function in a rat myocardial infarction model. Eur
J Heart Fail. 11:147–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye Y, Hu Z, Lin Y, Zhang C and Perez-Polo
JR: Downregulation of microRNA-29 by antisense inhibitors and a
PPAR-gamma agonist protects against myocardial
ischaemia-reperfusion injury. Cardiovasc Res. 87:535–544. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang F, Cui J, Liu X, Lv B, Liu X, Xie Z
and Yu B: Roles of microRNA-34a targeting SIRT1 in mesenchymal stem
cells. Stem Cell Res Ther. 6:1952015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H,
Xiao J, Shan H, Wang Z and Yang B: The muscle-specific microRNAs
miR-1 and miR-133 produce opposing effects on apoptosis by
targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci.
120:3045–3052. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu X, Wang Z, Wang R, Zhao F, Shi P,
Jiang Y and Pang X: Direct comparison of the potency of human
mesenchymal stem cells derived from amnion tissue, bone marrow and
adipose tissue at inducing dermal fibroblast responses to cutaneous
wounds. Int J Mol Med. 31:407–415. 2013.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu W, Chen J, Cong X, Hu S and Chen X:
Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem
cells. Stem cells. 24:416–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
König J, Huppertz B, Desoye G, Parolini O,
Fröhlich JD, Weiss G, Dohr G, Sedlmayr P and Lang I: Amnion-derived
mesenchymal stromal cells show angiogenic properties but resist
differentiation into mature endothelial cells. Stem Cells Dev.
21:1309–1320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
König J, Weiss G, Rossi D, Wankhammer K,
Reinisch A, Kinzer M, Huppertz B, Pfeiffer D, Parolini O and Lang
I: Placental mesenchymal stromal cells derived from blood vessels
or avascular tissues: What is the better choice to support
endothelial cell function? Stem Cells Dev. 24:115–131. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Opferman JT, Letai A, Beard C, Sorcinelli
MD, Ong CC and Korsmeyer SJ: Development and maintenance of B and T
lymphocytes requires antiapoptotic MCL-1. Nature. 426:671–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maurer U, Charvet C, Wagman AS, Dejardin E
and Green DR: Glycogen synthase kinase-3 regulates mitochondrial
outer membrane permeabilization and apoptosis by destabilization of
MCL-1. Mol Cell. 21:749–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: Mir-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Garzon R, Heaphy CE, Havelange V, Fabbri
M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA,
et al: MicroRNA 29b functions in acute myeloid leukemia. Blood.
114:5331–5341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y,
Jia WH and Zhuang SM: Effects of microRNA-29 on apoptosis,
tumorigenicity and prognosis of hepatocellular carcinoma.
Hepatology. 51:836–845. 2010.PubMed/NCBI
|
|
28
|
Lin CL, Lee PH, Hsu YC, Lei CC, Ko JY,
Chuang PC, Huang YT, Wang SY, Wu SL, Chen YS, et al: MicroRNA-29a
promotion of nephrin acetylation ameliorates hyperglycemia-induced
podocyte dysfunction. J Am Soc Nephrol. 25:1698–1709. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Roshan R, Shridhar S, Sarangdhar MA, Banik
A, Chawla M, Garg M, Singh VP and Pillai B: Brain-specific
knockdown of miR-29 results in neuronal cell death and ataxia in
mice. RNA. 20:1287–1297. 2014. View Article : Google Scholar : PubMed/NCBI
|
